If you have diabetes, prediabetes, or insulin resistance, you have probably been taught to focus almost entirely on blood sugar. Fasting glucose, A1C, and post-meal numbers tend to dominate every conversation about metabolic health. Those markers matter, but they are not designed to tell the full story of what is happening inside your body, especially in the early stages of insulin resistance.
Insulin resistance usually develops quietly. Long before blood sugar rises into a diagnosable range, the body compensates by producing more insulin to keep glucose under control. On lab work, things can look acceptable or only mildly off, even while the underlying problem is already progressing. This disconnect is one reason so many people feel confused when they are told they are “borderline” or “at risk,” but not diabetic yet.
One tool that helps explain this gray zone is the triglyceride–glucose index, otherwise known as the TyG index.
What the TyG Index Actually Is
The TyG index is a calculated number based on two routine fasting lab values you likely already have: fasting blood glucose and fasting triglycerides. These are not specialty tests or advanced markers. They are part of standard blood work. The cool part is that you can go back and calculate this yourself from years of prior bloodwork!
What makes the TyG index different is not the labs themselves, but the way they are interpreted together. Instead of looking at glucose and triglycerides as separate issues, TyG combines them into a single number that acts as a surrogate for insulin resistance and early metabolic dysfunction.
Why Glucose and Triglycerides Should be Looked at Together
Insulin resistance is not just a blood sugar problem. It affects how the body handles energy as a whole, especially at the level of the liver. The liver plays a central role in regulating both glucose and fat metabolism.
When insulin signaling is impaired, the liver tends to release more glucose into the bloodstream and package more fat as triglycerides. Blood sugar may stay within range for a long time because insulin levels rise to compensate, but triglycerides often begin to creep up as part of this metabolic strain.
Looking at glucose alone can miss that early dysfunction. Looking at triglycerides alone can make it seem like a cholesterol issue. Looking at them together provides a clearer picture of how well insulin is actually working. That is the gap the TyG index was designed to fill.
What the TyG Index Can Reveal That Standard Labs May Miss
The TyG index is useful because it reflects insulin resistance earlier than glucose-based screening alone. Higher TyG values are associated with greater metabolic risk and a higher likelihood of progressing from normal blood sugar to prediabetes or diabetes over time.
This includes people who are of normal weight and people whose glucose numbers do not yet look alarming. Insulin resistance does not only affect people with obesity, and it does not always show up first as high blood sugar. TyG helps surface that quieter dysfunction before things escalate.
What TyG Means if You Already Have Diabetes
If you already have diabetes, the TyG index does not replace A1C, glucose monitoring, or medical care. Instead, it offers another lens through which to understand metabolic health and future health risks. By shifting the focus from glucose alone to insulin resistance, TyG helps reframe the problem in a more physiologically grounded way.
What TyG Means if You Have Prediabetes or Insulin Resistance
For people with prediabetes or insulin resistance, the TyG index can be especially informative. It provides a way to quantify diabetes risk using labs that are already available, without waiting for blood sugar to cross a diagnostic threshold.
This can be helpful for people who feel dismissed because their numbers are “not bad enough yet,” even though something clearly feels off. TyG helps validate that concern by showing where metabolism may be heading, not just where it is today.
How Lifestyle Changes Relate to the TyG Index
Strategies that reduce insulin demand, stabilize fuel use, and improve metabolic flexibility, such as regular physical activity and certain dietary changes, can lower both fasting glucose and triglycerides, which are the inputs to the TyG index.
Because TyG is calculated from routine labs, it has the potential to reflect real metabolic improvement over time. It shifts the conversation away from short-term glucose control and toward longer-term metabolic health.
What the TyG Index Does Not Do
The TyG index is not a diagnostic tool. It does not replace clinical evaluation, and it does not tell you everything about metabolic health. Like any lab-based marker, it needs to be interpreted in context. Illness, medications, and recent dietary changes can all influence results. The goal of TyG is not to label or alarm, but to add clarity.
Why the TyG Index is Getting More Attention
The growing interest in the TyG index reflects a broader shift in how we think about metabolic health. Waiting for blood sugar to rise before taking action may miss a critical window. Insulin resistance develops long before diabetes shows up on paper.
The TyG index offers a practical way to see that earlier phase using information that already exists in routine lab work. It helps move the conversation from “Is this diabetes yet?” to “How well is insulin working, and what can I do to change that trajectory?”
How to Calculate Your Own TyG Index
While the calculation is not overly complex, if you don’t enjoy calculating logarithms, you may want to just use an online calculator.
Here is a very simple calculator that I found online to get you started (I’ll have my own soon): TyG Calculator
Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. The content of this article, provided by Insulin Resistance Lab, is for informational purposes only and does not constitute medical advice. It is not a substitute for professional advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about medical conditions, dietary changes, or lifestyle modifications. The information provided is intended for a general audience and may not apply to individual circumstances. Do not delay or disregard medical advice based on the content of this website. Insulin Resistance Lab (Holistic Fit LLC) assumes no responsibility for errors, omissions, or outcomes resulting from the use of this information. This content is provided “as is” without guarantees of completeness, accuracy, or timeliness. The author is not a licensed medical professional. References to specific products, research, or external websites are for informational purposes only and do not constitute endorsements or recommendations. Individual results may vary. Readers are encouraged to consult updated sources and verify information as scientific knowledge evolves.
References:
Cao, C., Hu, H., Xiao, P., Zan, Y., Chang, X., Han, Y., Zhang, X., & Wang, Y. (2024). Nonlinear relationship between triglyceride-glucose index and the risk of prediabetes and diabetes: a secondary retrospective cohort study. Frontiers in Endocrinology, 15, 1416634. https://doi.org/10.3389/fendo.2024.1416634
Guerrero-Romero, F., Simental-Mendía, L. E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M. G., Hernández-González, S. O., Jacques-Camarena, O., & Rodríguez-Morán, M. (2010). The product of triglycerides and glucose, a simple measure of insulin sensitivity: Comparison with the euglycemic–hyperinsulinemic clamp. The Journal of Clinical Endocrinology & Metabolism, 95(7), 3347–3351. https://doi.org/10.1210/jc.2010-0288
Freeman, A. M., Acevedo, L. A., & Pennings, N. (2023). Insulin resistance. In StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507839/
Li, S., Lin, G., Chen, J., Chen, Z., Xu, F., Zhu, F., Zhang, J., & Yuan, S. (2022). The effect of periodic ketogenic diet on newly diagnosed overweight or obese patients with type 2 diabetes. BMC Endocrine Disorders, 22(1), 34. https://doi.org/10.1186/s12902-022-00947-2
Liang, M., Pan, Y., Zhong, T., Zeng, Y., & Cheng, A. S. K. (2021). Effects of aerobic, resistance, and combined exercise on metabolic syndrome parameters and cardiovascular risk factors: a systematic review and network meta-analysis. Reviews in Cardiovascular Medicine, 22(4), 1523–1533. https://doi.org/10.31083/j.rcm2204156
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008). The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metabolic Syndrome and Related Disorders, 6(4), 299–304. https://doi.org/10.1089/met.2008.0034